SentryX has started a collaboration with the Medical Innovation and Technology Department of the Radboud University Medical Center, one of leading centers in the field of early HTA-modeling.

Together an HTA-model will be developed that connects the medical performance of BR-003 to the expected benefits for the patient, hospital, and society. Clinical trial results and post-marketing surveillance data will help validate and improve the model, which may also be applied to novel medical technologies under development.